The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
Each year, flu experts from around the world gather to map out recommendations for next winter's flu vaccine. This year, it's ...
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
Chemomab Therapeutics (CMMB) announced the successful completion of its End-of-Phase 2 Meeting with the FDA and alignment with FDA on the ...
Drug company executives on Tuesday touted their industry’s work to keep and make Americans healthy during a Washington event.
OS Therapies signed agreements for the commercial manufacture of OST-HER2 as it prepares for an FDA meeting and potential BLA submission. Phase 2b data show OST-HER2 significantly improved 12 ...
Northstrive Biosciences has submitted a pre-Investigational New Drug, or pre-IND, meeting request to the FDA for EL-22, a novel myostatin asset ...
Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute graft-versus-host disease (SR-aGvHD) in pediatric patients 2 months ...
The drug has already garnered rare pediatric disease ... As the company prepares for its regulatory meetings, the healthcare community and investors are watching closely for the potential impact ...